NCT06857799View on ClinicalTrials.gov

A Study on the Safety, Tolerability and Pharmacokinetics of WS-0101 Tablets in Chinese Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

27

Participants

Timeline

Start Date

May 13, 2024

Primary Completion Date

June 28, 2024

Study Completion Date

September 23, 2024

Conditions
Healthy Adult Subjects
Interventions
PROCEDURE

Light Power Density and Light Duration 40 mW/cm²*1000s

Use light power density and light duration 40 mW/cm²\*1000s treatment

PROCEDURE

Light Power Density and Light Duration 80 mW/cm²*1000s

Use light power density and light duration 80 mW/cm²\*1000s treatment

Trial Locations (1)

100035

Peking University First Hospital, Beijing

All Listed Sponsors
lead

Peking University First Hospital

OTHER

NCT06857799 - A Study on the Safety, Tolerability and Pharmacokinetics of WS-0101 Tablets in Chinese Healthy Subjects | Biotech Hunter | Biotech Hunter